Find our Science Published in
"A passionate and deeply knowledgeable team seeking to create meaningful societal impact by harnessing the power of exponential technologies."
CurrentPress
Journa Unveils Bondia™: A Daily Synbiotic Medical Food for the Dietary Management of Bone Loss Associated with Menopause, Weight, and Aging
Journa is excited to announce the introduction of Bondia™, scientifically formulated daily synbiotic medical food designed to support bone health and slow bone loss associated with menopause, weight and aging.
Ilissa Larimore Appointed Chief Commercial Officer at Solarea Bio
Solarea announces the appointment of Ilissa Larimore as Chief Commercial Officer (CCO). Ilissa joins Solarea Bio with over 20 years of experience in consumer health, personalized wellness and practitioner engagement to help individuals achieve optimal health.
Solarea Bio Announces the Beta Launch of Bondia™, a Novel Daily Medical Food Helping Menopausal Women Manage Bone Loss
The complete beta launch experience, known as the Beta Complete Journey, includes a baseline total body DEXA scan, a year of Bondia™ capsules, and access to an accompanying mobile app.
The NIH/National Institute on Aging has awarded a R01 $3 million grant to study the impact of a medical food developed by Solarea Bio
Hebrew SeniorLife, United States Department of Agriculture (USDA) Human Nutrition Research Center on Aging (HNRCA) at Tufts University, Maine Medical Center Research Institute, and Solarea Bio are grant recipients.